Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels

被引:39
作者
Cano, A [1 ]
Castelo-Branco, C [1 ]
Tarín, JJ [1 ]
机构
[1] Hosp Clin Univ, Fac Med, Valencia, Spain
关键词
GH; hormone replacement therapy; IGF-1; IGFBP; menopause;
D O I
10.1016/S0015-0282(98)00432-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the effects of menopause and three different formulations of E-2 plus medroxyprogesterone acetate on serum concentrations of basal and growth hormone-releasing hormone (GHRH)stimulated growth hormone (GH), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein (IGFBP)-1, IGFBP-3, insulin, and C peptide. Design: Prospective, controlled trial. Setting: Menopausal outpatient clinic at an academic tertiary care hospital. Patient(s): Nineteen postmenopausal women with different menopausal ages. Seventeen premenopausal women were included as controls. Intervention(s): Oral estrogen (E-2 valerate, 2 mg/d) or transdermal estrogen (50-mu g or 100-mu g E-2 patch) was administered for 8 weeks. Medroxyprogesterone acetate (5 mg/d) was administered during weeks 3, 4, 7, and 8 of each protocol. Blood samples were collected before treatment and after the completion of each protocol from postmenopausal women, and on cycle days 6-8 from premenopausal women. Main Outcome Measure(s): Levels of GH, IGF-1, IGFBP-1, IGFBP-3, insulin, and C peptide. Result(s): Basal GH levels were negatively correlated with age in premenopausal women but not in postmenopausal women. The area under the GHRH-induced GH curve decreased in older postmenopausal women after the oral estrogen protocol. Levels of IGF-1 diminished after the oral E-2 protocol in postmenopausal women. Conclusion(s): The administration of oral, but not transdermal, E-2 plus medroxyprogesterone acetate at the usual clinical doses used in postmenopausal women decreased IGF-1 levels and the response of GH to GHRH in older women. No substantial changes were detected in IGFBP-1, IGFBP-3, insulin, or C peptide levels. (Fertil Steril(R) 1999,71.261-7. (C) 1999 by American Society for Reproductive Medicine.).
引用
收藏
页码:261 / 267
页数:7
相关论文
共 23 条
[1]   Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: A clinical research center study [J].
Bellantoni, MF ;
Vittone, J ;
Campfield, AT ;
Bass, KM ;
Harman, SM ;
Blackman, MR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08) :2848-2853
[2]   EFFECTS OF PROGESTIN-OPPOSED TRANSDERMAL ESTROGEN ADMINISTRATION ON GROWTH-HORMONE AND INSULIN-LIKE GROWTH FACTOR-I IN POSTMENOPAUSAL WOMEN OF DIFFERENT AGES [J].
BELLANTONI, MF ;
HARMAN, SM ;
CHO, DE ;
BLACKMAN, MR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (01) :172-178
[3]  
Birkhauser M, 1996, HUM REPROD, V11, P975
[4]   Relationships between insulin-like growth hormone factor-I and estradiol in reproductive aging [J].
Blake, EJ ;
Adel, T ;
Santoro, N .
FERTILITY AND STERILITY, 1997, 67 (04) :697-701
[5]   Regulation of somatic growth and the somatotropic axis by gonadal steroids: Primary effect on insulin-like growth factor I gene expression and secretion [J].
Borski, RJ ;
Tsai, W ;
DeMottFriberg, R ;
Barkan, AL .
ENDOCRINOLOGY, 1996, 137 (08) :3253-3259
[6]   Serum IGF-1 and binding proteins 1 and 3 in postmenopausal women and the effects of estrogen [J].
Carmina, E ;
LoDico, G ;
Carollo, F ;
Stanczyk, FZ ;
Lobo, RA .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 1996, 3 (02) :85-89
[7]   REGULATION OF GROWTH-HORMONE AND SOMATOMEDIN-C SECRETION IN POSTMENOPAUSAL WOMEN - EFFECT OF PHYSIOLOGICAL ESTROGEN REPLACEMENT [J].
DAWSONHUGHES, B ;
STERN, D ;
GOLDMAN, J ;
REICHLIN, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (02) :424-432
[8]   AGE-RELATED-CHANGES IN SERUM INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINS IN WOMEN [J].
DONAHUE, LR ;
HUNTER, SJ ;
SHERBLOM, AP ;
ROSEN, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (03) :575-579
[9]   Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - A clinical research center study [J].
Friend, KE ;
Hartman, ML ;
Pezzoli, SS ;
Clasey, JL ;
Thorner, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2250-2256
[10]   Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: The Rancho Bernardo study [J].
GoodmanGruen, D ;
BarrettConnor, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) :4268-4271